Prediction of steroid demand in the treatment of patients with ulcerative colitis by immunohistochemical analysis of the mucosal microenvironment and immune checkpoint: role of macrophages and regulatory markers in disease severity

Genomic Profile and Pathologic Features of Diffuse Large B-Cell Lymphoma Subtype of Methotrexate-associated Lymphoproliferative Disorder in Rheumatoid Arthritis Patients

(2018) Joaquim Carreras et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Clinicopathological characteristics and genomic profile of primary sinonasal tract diffuse large B cell lymphoma (DLBCL) reveals gain at 1q31 and RGS1 encoding protein; high RGS1 immunohistochemical expression associates with poor overall survival in DLBC

(2017) Joaquim Carreras et al.   HISTOPATHOLOGY

Haematopoietic prolyl hydroxylase-1 deficiency promotes M2 macrophage polarization and is both necessary and sufficient to protect against experimental colitis

(2017) Sophie Van Welden et al.   JOURNAL OF PATHOLOGY

Disease activity and mucosal healing in inflammatory bowel disease: a new role for histopathology?

(2017) Rish K. Pai et al.   VIRCHOWS ARCHIV

Ulcerative Colitis

(2016) Elena Sonnenberg et al.   DIGESTION

Human macrophages induce CD4+ Foxp3+ regulatory T cells via binding and re-release of TGF-β

(2016) Angelika Schmidt et al.   IMMUNOLOGY AND CELL BIOLOGY

The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible

(2016) Damian Szklarczyk et al.   NUCLEIC ACIDS RESEARCH

The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation

(2016) Kankana Bardhan et al.   Frontiers in Immunology

Decrease of CD4+CD25+CD127lowFoxP3+regulatory T cells with impaired suppressive function in untreated ulcerative colitis patients

(2015) Mousa Mohammadnia-Afrouzi et al.   AUTOIMMUNITY

Factors Associated With Poor Outcomes in Adults With Newly Diagnosed Ulcerative Colitis

(2015) Walter Reinisch et al.   Clinical Gastroenterology and Hepatology

Immunopathogenesis of IBD: current state of the art

(2015) Heitor S. P. de Souza et al.   Nature Reviews Gastroenterology & Hepatology

Protective effects of Fc-fused PD-L1 on two different animal models of colitis

(2014) Mi-Young Song et al.   GUT

Soluble CD163, a Specific Macrophage Activation Marker, is Decreased by Anti-TNF-αAntibody Treatment in Active Inflammatory Bowel Disease

(2014) A. Dige et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation

(2013) M Zaeem Cader et al.   GUT

Prognostic Value of Serologic and Histologic Markers on Clinical Relapse in Ulcerative Colitis Patients With Mucosal Healing

(2012) Talat Bessissow et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations

(2012) Núria Planell et al.   GUT

Identification of FOXP3-negative regulatory T-like (CD4+CD25+CD127low) cells in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome

(2011) Keisuke Otsubo et al.   CLINICAL IMMUNOLOGY

Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47

(2011) Carl A Anderson et al.   NATURE GENETICS

HVEM Signalling Promotes Colitis

(2011) Corinne Schaer et al.   PLoS One

Increased proportion of CD16+ NK cells in the colonic lamina propria of inflammatory bowel disease patients, but not after azathioprine treatment

(2010) A. W. Steel et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Feedback control of regulatory T cell homeostasis by dendritic cells in vivo

(2009) Guillaume Darrasse-Jèze et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Prevalence of ulcerative colitis and Crohn’s disease in Japan

(2009) Keiko Asakura et al.   JOURNAL OF GASTROENTEROLOGY

A crucial role for HVEM and BTLA in preventing intestinal inflammation

(2008) Marcos W. Steinberg et al.   JOURNAL OF EXPERIMENTAL MEDICINE